 NOVATO, CA ACCESSWIRE June 28, 2021 Mosaic ImmunoEngineering Inc. Mosaic or the Company, OTCQB:CPMV, a development-stage biotechnology company focused onimmunotherapies to treat and prevent cancer and infectious diseases through innate and adaptive immune activation, announced today that it has submitted its initial application to list the companys common stock on the Nasdaq Capital Market. The listing of Mosaics shares on Nasdaq will be subject to review of the Companys listing application by Nasdaq and the Companys successful compliance with all of Nasdaqs applicable governance and regulatory requirements. 